Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

European Innovation Council · Running

NatProLub Nature-inspired Prophylactic Lubricants Against Hiv-1 and Hsv-2

Coordinator
Uppsala Universitet, Sweden
Runs
1 January 2024 to 31 December 2027
Status
Running
EU funding
€3.6m
Total cost
€3.6m
Partners
8 organisations in 6 countries
Type
European Innovation Council
Grant agreement
101130633

What the project is doing

In the project's own words, from its summary on CORDIS.

Currently, there are no vaccines against HIV (human immunodeficiency virus) and HSV (herpes simplex virus) infections. Condom, when used properly, are the most effective means of prophylaxis against viral transmission. However, there is a significant gender imbalance in condom use because women are not always in control over their use. In addition, women are at least twice as likely as men to contract sexually transmitted infections (STIs) from infected partners.

Several STIs, including HIV, are underdiagnosed due to asymptomatic infections and/or lack of testing facilities. This is particularly problematic for women from African countries, who are at high risk of contracting STIs but have poor access to testing facilities. Alternatives to condoms that use established antivirals for HIV prophylaxis come with issues such as antimicrobial resistance and low adherence in practice in high-risk groups.

There are also no means other than condoms for prophylaxis against HSV. Co-infection with HIV/HSV results in a vicious cycle of mutual facilitation, as individuals who are carriers of HSV have a three- to fourfold increased risk of contracting HIV. Inspired by nature, NatProLub develops a radically novel prophylactic approach to HIV and HSV prophylaxis through the use of lubricants. By targeting women, who are particularly at risk, NatProLub has a clear vision for a user-friendly, prophylactic product that can redress the gender imbalance in sexual health while offering a low risk of side effects and avoiding the risk of developing antimicrobial resistance.

The members of the NatProLub consortium have very strong backgrounds in relevant but complementary scientific disciplines that will contribute to the development of prophylactic lubricants for end users and have previous successful experience in managing large scientific projects, the creation of spin-off companies, and maintaining well-developed professional networks in academia, industry, and healthcare.

Who is involved

OrganisationCityCountryRole
Uppsala UniversitetUppsalaSwedenCoordinator
Technische Universitaet MuenchenMuenchenGermanyParticipant
Cirqle Biomedical Contraception ApsKobenhavnDenmarkParticipant
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceParticipant
Universita Degli Studi Di TorinoTorinoItalyParticipant
Cellularis Biomodels LdaIlhavoPortugalParticipant
Karolinska InstitutetStockholmSwedenParticipant
Kungliga Tekniska HoegskolanStockholmSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI